Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas

Hepatitis B virus (HBV) infection remains an important issue of global public health. Although current antiviral therapy has dramatically reduced the mortality and morbidity of chronic hepatitis B (CHB), it fails to cure it. Rebound viremia often occurs after stopping antiviral therapy. Persistent H...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu-Chan, Yang, Hung-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781244/
https://www.ncbi.nlm.nih.gov/pubmed/35062208
http://dx.doi.org/10.3390/v14010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781244/
https://www.ncbi.nlm.nih.gov/pubmed/35062208
http://dx.doi.org/10.3390/v14010004

Ejemplares similares